Publication | Open Access

N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist

Medicinal ChemistryMedicineMechanism Of ActionPharmacological AgentNeuropharmacologyPharmacotherapyNeurosciencePharmacologyPharmaceutical ChemistryDrug Discovery